Hikal profitability ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Returns
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−4.0%−4.0%7.4%6.0%7.1%
−2.0%−2.0%3.6%2.9%3.4%
3.3%3.3%11.2%8.7%9.4%
2.0%1.9%7.1%5.5%5.9%
Margins
13.4%12.9%17.7%15.0%12.7%
3.3%3.3%10.4%8.4%7.3%
—93.3%59.3%−0.6%—
−3.3%−4.6%6.7%5.4%5.2%
−1.9%−2.9%4.9%3.9%3.9%
——4.9%3.9%—
9.0%9.0%7.7%−1.0%0.6%
Additional
41.5%37.7%26.7%27.1%25.6%
—−25.2%16.3%21.3%15.7%
−4.0%−5.0%6.2%4.7%6.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HIKAL₹202.10

Hikal Limited

· Pharma & Health
₹ CrorePeersPANACEABIODCALSAIPARENTINDOCOSOLARAWINDLASINDSWFTLABHESTERBIOMcap ₹2,496 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity7.126.007.41-3.97-3.97
Return on Assets3.412.863.62-1.99-1.99
Return on Capital Employed9.358.6511.183.303.30
Return on Invested Capital5.945.477.071.892.04
Margins
EBITDA Margin12.7114.9617.6612.8713.39
Operating Margin7.328.3710.433.303.30
Incremental Operating Margin—-0.5759.2893.34—
Pretax Margin5.215.356.66-4.57-3.33
Net Income Margin3.873.904.88-2.85-1.95
Net Income to Common Margin—3.904.88——
FCF Margin0.63-0.987.698.998.99
Additional
Effective Tax Rate25.6127.1226.6637.6841.52
Dvd Payout Ratio15.7421.3116.30-25.20—
Sustainable Growth Rate6.004.726.20-4.97-3.97
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.